A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity

Human Molecular Genetics

Volumn 13, Issue 21, 2004, Pages 2647-2657

  Katzov, Hagit ^a   Bennet, Anna M ^a   Kehoe, Patrick ^b   Wiman, Björn ^c   Gatz, Margaret ^a,d   Blennow, Kaj ^e   Lenhard, Boris ^a   Pedersen, Nancy L ^a,d   de Faire, Ulf ^a   Prince, Jonathan A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GLUCOSE; INSULIN;

ADULT; AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; ARTICLE; CLADISTICS; CONTROLLED STUDY; EUROPE; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INSULIN BLOOD LEVEL; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; OBESITY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SWEDEN;

ALZHEIMER DISEASE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC MARKERS; GENOME, HUMAN; HAPLOTYPES; HUMANS; INSULIN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; MODELS, GENETIC; MYOCARDIAL INFARCTION; OBESITY; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; VARIATION (GENETICS);

INSERTION SEQUENCES;

EID: 8444239673     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh286     Document Type: Article

References (57)

1. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P. and Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest., 86, 1343-1346.
2. Cox, R., Bouzekri, N., Martin, S., Southam, L., Hugill, A., Golamaully, M., Cooper, R., Adeyemo, A., Soubrier, F., Ward, R. et al. (2002) Angiotensin-1-converting enzyme (ACE) plasma concentration is influenced by multiple ACE-linked quantitative trait nucleotides. Hum. Mol. Genet., 11, 2969-2977.
3. Bengtsson, K., Orho-Melander, M., Lindblad, U., Melander, O., Bog-Hansen, E., Ranstam, J., Rastam, L. and Groop, L. (1999) Polymorphism in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg hypertension and diabetes project. J. Hypertens., 17, 1569-1575.
4. Narain, Y., Yip, A., Murphy, T., Brayne, C., Easton, D., Evans, J.G., Xuereb, J., Cairns, N., Esiri, M.M., Furlong, R.A. et al. (2000) The ACE gene and Alzheimer's disease susceptibility. J. Med. Genet., 37, 695-697.
5. Butler, R., Morris, A.D. and Struthers, A.D. (1997) Angiotensin-converting enzyme gene polymorphism and cardiovascular disease. Clin. Sci. (Lond.), 93, 391-400.
6. Tiret, L., Rigat, B., Visvikis, S., Breda, C., Corvol, P., Cambien, F. and Soubrier, F. (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am. J. Hum. Genet., 51, 197-205.
7. McKenzie, C.A., Abecasis, G.R., Keavney, B., Forrester, T., Ratcliffe, P.J., Julier, C., Connell, J.M., Bennett, F., McFarlane-Anderson, N., Lathrop, G.M. et al. (2001) Trans-ethnic fine mapping of a quantitative trait locus for circulating angiotensin I-converting enzyme (ACE). Hum. Mol. Genet., 10, 1077-1084.
8. Farrall, M., Keavney, B., McKenzie, C., Delepine, M., Matsuda, F. and Lathrop, G.M. (1999) Fine-mapping of an ancestral recombination breakpoint in DCP1. Nat. Genet., 23, 270-271.
9. Keavney, B., McKenzie, C.A., Connell, J.M., Julier, C., Ratcliffe, P.J., Sobel, E., Lathrop, M. and Farrall, M. (1998) Measured haplotype analysis of the angiotensin-I converting enzyme gene. Hum. Mol. Genet., 7, 1745-1751.
10. Rieder, M.J., Taylor, S.L., Clark, A.G. and Nickerson, D.A. (1999) Sequence variation in the human angiotensin converting enzyme. Nat. Genet., 22, 59-62.
11. Villard, E., Tiret, L., Visvikis, S., Rakotovao, R., Cambien, F. and Soubrier, F. (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. Am. J. Hum. Genet., 58, 1268-1278.
12. Zhu, X., McKenzie, C.A., Forrester, T., Nickerson, D.A., Broeckel, U., Schunkert, H., Doering, A., Jacob, H.J., Cooper, R.S. and Rieder, M.J. (2000) Localization of a small genomic region associated with elevated ACE. Am. J. Hum. Genet., 67, 1144-1153.
13. Johnson, G.C., Esposito, L., Barratt, B.J., Smith, A.N., Heward, J., DiGenova, G., Ueda, H., Cordell, H.J., Eaves, I.A., Dudbridge, F. et al. (2001) Haplotype tagging for the identification of common disease genes. Nat. Genet., 29, 233-237.
14. Soubrier, F., Martin, S., Alonso, A., Visvikis, S., Tiret L., Matsuda, F., Lathrop, G.M. and Farrall, M. (2002) High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity. Eur. J. Hum. Genet., 10, 553-561.
15. Templeton, A.R. (1995) A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping or DNA sequencing. V. Analysis of case/control sampling designs: Alzheimer's disease and the apoprotein E locus. Genetics, 140 403-409.
16. Durrant, C., Zondervan, K.T., Cardon, L.R., Hunt, S., Deloukas, P. and Morris, A.P. (2004) Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. Am. J. Hum. Genet., 75, 35-43.
17. Kehoe, P.G., Katzov, H., Feuk, L., Bennet, A.M., Johansson, B., Wiman, B., de Faire, U., Cairns, N.J., Wilcock, G.K., Brookes, A.J. et al. (2003) Haplotypes extending across ACE are associated with Alzheimer's disease. Hum. Mol. Genet., 12, 859-867.
18. Zhu, X., Bouzekri, N., Southam, L., Cooper, R.S., Adeyemo, A., McKenzie, C.A., Luke, A., Chen, G., Elston, R.C. and Ward, R. (2001) Linkage and association analysis of angiotensin I-converting enzyme ( ACE)-gene polymorphisms with ACE concentration and blood pressure. Am. J. Hum. Genet., 68, 1139-1148.
19. Reuterwall, C., Hallqvist, J., Ahlbom, A., De Faire, U., Diderichsen, F., Hogstedt, C., Pershagen, G., Theorell, T., Wiman, B. and Wolk, A. (1999) Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J. Intern. Med., 246, 161-174.
20. Leander, K., Wiman, B., Hallqvist, J., Sten-Linder, M. and de Faire, U. (2003) PAI-1 level and the PAI-1 4G/5G polymorphism in relation to risk of non-fatal myocardial infarction: results from the Stockholm Heart Epidemiology Program (SHEEP). Thromb. Haemost., 89, 1064-1071.
21. North, K., Howard, B. and Welty, T. (2003) Genetic and environmental contributions to cardiovascular disease risk in American Indians: the strong heart family study. Am. J. Epidemiol., 157 303-314.
22. Broeckel, U., Hengstenberg, C., Mayer, B., Holmer, S., Martin, L.J., Comuzzie, A.G., Blangero, J., Nurnberg, P., Reis, A., Riegger, G.A. et al. (2002) A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nat. Genet., 30, 210-214.
23. Dobbelsteyn, C.J., Joffres, M.R., MacLean, D.R. and Flowerdew, G. (2001) A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int. J. Obestr. Relat. Metab. Disord., 25, 652-661.
24. Kehoe, P.G. (2003) The renin-angiotensin-aldosterone system and Alzheimer's disease? J. Renin Angiotensin Aldosterone Syst., 4, 80-93.
25. Schachter, F., Faure-Delanef, L., Guenot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L. and Cohen, D. (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat. Genet., 6 29-32.
26. Galinsky, D., Tysoe, C., Brayne, C.E., Easton, D.F., Huppert, F.A., Dening, T.R., Paykel, E.S. and Rubinsztein, D.C. (1997) Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis, 129, 177-183.
27. Matthews, J.M. and Sunde, M. (2002) Zinc fingers-folds for many occasions. IUBMB Life, 54, 351-355.
28. Cartegni, L., Wang, J., Zhu, Z., Zhang, M.Q. and Krainer, A.R. (2003) ESEfinder: A web resource to identify exonic splicing enhancers. Nucl. Acids Res., 31, 3568-3571.
29. Zingone, A., Dominijanni, A., Mele, E., Marasco, O., Melina, F., Minchella, P., Quaresima, B., Tiano, M.T., Gnasso, A., Pujia, A. et al. (1994) Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood glucose levels. Hum. Genet., 94, 207-209.
30. Strazzullo, P., Iacone, R., Iacoviello, L., Russo, O., Barba, G., Russo, P., D'Orazio, A., Barbato, A., Cappuccio, F.P., Farinaro, E. et al. (2003) Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study. Ann. Intern. Med., 138, 17-23.
31. Shiuchi, T., Cui, T.X., Wu, L., Nakagami, H., Takeda-Matsubara, Y., Iwai, M. and Horiuchi, M. (2002) ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO. Hypertension, 40, 329-334.
32. Alkharouf, J., Nalinikumari, K., Corry, D. and Tuck, M. (1993) Long-term effects of the angiotensin converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus. Am. J. Hypertens., 6, 337-343.
33. McFarlane, S.I., Kumar, A. and Sowers, J.R. (2003) Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease. Am. J. Cardiol., 91, 30H-37H.
34. Henriksen, E.J. and Jacob, S. (2003) Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition. J. Cell Physiol., 196, 171-179.
35. O'Donnell, C.J., Lindpaintner, K., Larson, M.G., Rao, V.S., Ordovas, J.M., Schaefer, E.J., Myers, R.H. and Levy, D. (1998) Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation, 97, 1766-1772.
36. Wittrup, H.H., Tybjaerg-Hansen, A., Steffensen, R., Deeb, S.S., Brunzell, J.D., Jensen, G. and Nordestgaard, B.G. (1999) Mutations in the lipoprotein lipase gene associated with ischemic heart disease in men. The Copenhagen city heart study. Arterioscler. Thromb. Vasc. Biol., 19, 1535-1540.
37. Higaki, J., Baba, S., Katsuya, T., Sato, N., Ishikawa, K., Mannami, T., Ogata, J. and Ogihara, T. (2000) Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: the Suita Study. Circulation, 101 2060-2065.
38. Karamohamed, S., Demissie, S., Volcjak, J., Liu, C., Heard-Costa, N., Liu, J., Shoemaker, C.M., Panhuysen, C.I., Meigs, J.B., Wilson, P. et al. (2003) Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes, 52, 1562-1567.
39. McCarthy, J.J., Meyer, J., Moliterno, D.J., Newby, L.K., Rogers, W.J. and Topol, E.J. (2003) Evidence for substantial effect modification by gender in a large-scale genetic association study of the metabolic syndrome among coronary heart disease patients. Hum. Genet. 114, 87-98.
40. Sagnella, G.A., Rothwell, M.J., Onipinla, A.K., Wicks, P.D., Cook, D.G. and Cappuccio, F.P. (1999) A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: relationships with gender, hypertension and impaired glucose metabolism. J. Hypertens., 17, 657-664.
41. Gustafson, D., Rothenberg, E., Blennow, K., Steen, B. and Skoog, I. (2003) An 18-year follow-up of overweight and risk of Alzheimer disease. Arch. Intern. Med., 163, 1524-1528.
42. Riordan, J.F. (2003) Angiotensin-I-converting enzyme and its relatives. Genome Biol., 4, 225.
43. Georgiadis, D., Beau, F., Czarny, B., Cotton, J., Yiotakis, A. and Dive, V. (2003) Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ. Res., 93 148-154.
44. Hu, J., Igarashi, A., Kamata, M. and Nakagawa, H. (2001) Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (Abeta); retards Abeta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J. Biol. Chem., 276, 47863-47868.
45. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J.P., Arveiler, D., Luc, G., Bard, J.M., Bara, L., Ricard, S. et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature, 359, 641-644.
46. Haiman, C.A., Henderson, S.O., Bretsky, P., Kolonel, L.N. and Henderson, B.E. (2003) Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res., 63, 6984-6987.
47. Kehoe, P.G., Russ, C., McIlory, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B. et al. (1999) Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease. Nat. Genet., 21, 71-72.
48. Bennet, A.M., Prince, J.A., Fei, G.Z., Lyrenas, L., Huang, Y., Wiman, B., Frostegard, J. and Faire, U. (2003) Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis, 171, 359-367.
49. Andreasen, N., Hesse, C., Davidsson, P., Minthon, L., Wallin, A., Winblad, B., Vanderstichele, H., Vanmechelen, E. and Blennow, K. (1999) Cerebrospinal fluid beta-amytoid(1-42) in Alzheimer disease: differences between early-and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol., 56, 673-680.
50. Lichtenstein, P., De Faire, U., Floderus, B., Svartengren, M., Svedberg, P. and Pedersen, N.L. (2002) The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J. Intern. Med., 252, 184-205.
51. Prince, J.A., Feuk, L., Howell, W.M., Jobs, M., Emahazion, T., Blennow, K. and Brookes, A.J. (2001) Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res., 11, 152-162.
52. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W.W. and Lenhard, B. (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucl. Acids Res., 32 (Database issue), D91-D94.
53. Karolchik, D., Baertsch, R., Diekhans, M., Furey, T.S., Hinrichs, A., Lu, Y.T., Roskin, K.M., Schwartz, M., Sugnet, C.W., Thomas, D.J. et al. (2003) The UCSC Genome Browser Database. Nucl. Acids Res., 31, 51-54.
54. Lenhard, B., Sandelin, A., Mendoza, L., Engstrom, P., Jareborg, N. and Wasserman, W.W. (2003) Identification of conserved regulatory elements by comparative genome analysis. J. Biol., 2 13.
55. Niu, T., Qin, Z.S., Xu, X. and Liu, J.S. (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am. J. Hum. Genet., 70, 157-169.
56. Hill, W. (1974) Estimation of linkage disequilibrium in randomly mating populations. Heredity, 33, 229-239.
57. Barton, M., Carmona, R., Morawietz, H., d'Uscio, L.V., Goettsch, W., Hillen, H., Haudenschild, C.C., Krieger, J.E., Munter, K., Lattmann, T. et al. (2000) Obesity is associated with tissue-specific activation of renal angiotensin-converting enzyme in vivo: evidence for a regulatory role of endothelin. Hypertension 35, 329-336.